Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/7475
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yenny Triamyanti, Vincentina | - |
dc.contributor.author | Herawati, Fauna | - |
dc.contributor.author | Yulia, Rika | - |
dc.contributor.author | Kadir Jaelani, Abdul | - |
dc.date.accessioned | 2024-11-07T04:22:58Z | - |
dc.date.available | 2024-11-07T04:22:58Z | - |
dc.date.issued | 2022-08-31 | - |
dc.identifier.issn | 25808303 | - |
dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/7475 | - |
dc.description.abstract | Abstract Background: Coronavirus Disease 2019 (Covid-19) is an infectious disease. Common signs and symptoms of Covid-19 infection include acute respiratory distress such as fever, cough and shortness of breath. Analysis of drug use in Non-Ventilator Covid-19 patients needs to be carried out to provide an overview of drug therapy currently being used based on the Covid-19 Management Guidelines Edition 3rd because so far, there has not been a single type of drug that has received marketing authorization for Covid-19 therapy. Objectives: This study aims to determine patient profiles, therapeutic outcomes, suitability of drug use with Covid-19 Management Guidelines 3 rd edition, the quantity of antibiotic use using the DDD/100 patient-days method and antivirals. Methods: The method used in this study is an observational design study which was analyzed descriptively with retrospective data collection. Result: Based on the profile of drug use in COVID-19 patients, there are 31 types of drug classes. The most consumed drugs were antibacterial (91%) and analgesics (91%), followed by vitamins (89%) and supplements (85%). Based on the DDD/100 patient-days value, the most widely used antibiotics were Azithromycin. Conclusion: The patient's profile at the time of admission to the hospital was 44% moderate and 56% severe. The condition of patients at the time of discharge from the hospital with a moderate degree using antivirals and antibiotics were more recovered and returned home with improvements with percentages of 84.1% and 88.64%, respectively. Keywords: covid-19, non-ventilator patients, antibiotic, antiviral | en_US |
dc.publisher | Faculty of Pharmacy Univesrsitas Airlangga | en_US |
dc.subject | covid-19, | en_US |
dc.subject | non-ventilator patients, | en_US |
dc.subject | antibiotic, | en_US |
dc.subject | antiviral | en_US |
dc.title | Analysis of Drug Use in Non-Ventilator Covid-19 Patients at Bangil Hospital | en_US |
dc.type | Article | en_US |
Appears in Collections: | VOL 9 NO 2 2022 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
168-176.pdf | 466.75 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.